Projected 30- day out-of-pocket costs and total spending on pancreatic enzyme replacement therapy under Medicare Part D

Arjun Gupta, Naveen Premnath, Ramy Sedhom, Muhammad S. Beg, Rohan Khera, Daniel A. Laheru, Stacie B. Dusetzina

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1009-1010
Number of pages2
JournalPancreatology
Volume21
Issue number5
DOIs
StatePublished - Aug 1 2021
Externally publishedYes

Bibliographical note

Funding Information:
We thank Leonce Nshuti, MS for their help in creating the dataset. Arjun Gupta and Ramy Sedhom is supported by a Conquer Cancer Foundation American Society of Clinical Oncology Young Investigator Award . There are no conflicts of interest for any author.

Keywords

  • Cost
  • Exocrine pancreatic insufficiency
  • Medicare
  • Pancreatic ductal adenocarcinoma (PDAC)
  • Pancreatic enzymes

PubMed: MeSH publication types

  • Journal Article

Cite this